The company said it’s working to produce up to 1 billion doses of its Covid-19 vaccine this year. The U.S. is on track to secure 100 million doses of Moderna’s vaccine by the end of March and additional 100 million by June, the Massachusetts-based company said in a statement.
The U.S. Food and Drug Administration granted Moderna’s Covid-19 vaccine emergency authorization for people 18 and older the United States in December and has started the drug’s initial roll-out.
The federal government has agreed to buy 200 million doses of Moderna’s vaccine with the option to secure an additional 300 million doses, the company said.
This is a developing story. Please check back later for updates.
View original post